Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

comparisons

Retatrutide vs Semaglutide: Triple vs Single Agonist Phase 2 trials reported 24.2% weight loss for retatrutide vs 14.9% for semaglutide in STEP 1 — but only one is FDA-approved. Full side-by-side. Liraglutide vs Semaglutide: 2.5x Weight Loss Gap STEP 8 head-to

This comparison does not assign a generated winner or score.

  • Retatrutide vs Semaglutide: Triple vs Single Agonist
  • Phase 2 trials reported 24.2% weight loss for retatrutide vs 14.9% for semaglutide in STEP 1 — but only one is FDA-approved. Full side-by-side.
  • Liraglutide vs Semaglutide: 2.5x Weight Loss Gap
  • STEP 8 head-to-head: 15.8% vs 6.4% weight loss. Side-by-side dosing, side effects, and cost — and which one to actually pick.
  • Cagrilintide vs Semaglutide: Different Paths
  • They target different receptors entirely — and combining them produces 22.7% weight loss. Mechanism, efficacy, and when to use each.
More references

Related material

Comparison

Price Comparisons

Compare 5-Amino-1MQ Prices Find the best deals from trusted vendors Compare AOD-9604 Prices Compare Tesamorelin Prices Compare Tesofensine Prices Compare Tirzepatide Prices Compar…

View details →
Comparison

comparison

GLP-4 vs GLP-5: Bioglutide vs VRX-0075 Bioglutide (GLP-4) adds muscle-sparing IGF-1 and has oral human data; VRX-0075 (GLP-5) adds amylin for deeper loss but is rat-only. Full com…

View details →